Advertisement
UK markets close in 27 minutes
  • FTSE 100

    8,441.07
    +59.72 (+0.71%)
     
  • FTSE 250

    20,654.36
    +123.06 (+0.60%)
     
  • AIM

    790.58
    +6.88 (+0.88%)
     
  • GBP/EUR

    1.1620
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2511
    -0.0013 (-0.11%)
     
  • Bitcoin GBP

    48,681.76
    -466.07 (-0.95%)
     
  • CMC Crypto 200

    1,279.33
    -78.68 (-5.80%)
     
  • S&P 500

    5,217.50
    +3.42 (+0.07%)
     
  • DOW

    39,466.14
    +78.38 (+0.20%)
     
  • CRUDE OIL

    79.47
    +0.21 (+0.26%)
     
  • GOLD FUTURES

    2,368.70
    +28.40 (+1.21%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,782.21
    +95.61 (+0.51%)
     
  • CAC 40

    8,232.22
    +44.57 (+0.54%)
     

These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win

These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win

Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB) are both keen to compete in the market for Alzheimer's disease therapies. Biogen's prior attempt at an Alzheimer's medicine to hit the market was a train wreck, but its latest drug seems to be avoiding a repeat. Meanwhile, Eli Lilly has yet to submit its candidate for regulatory review.